HOME   |   ABOUT US   |   THE PRODUCT   |   BIBLIOGRAPHY   |   BOARD OF DIRECTORS   |   FAQ's   |   CONTACT
 
 
BIBLIOGRAPHY

References

Alayash, A. I. Hemoglobin-based blood substitutes and the hazards of blood radicals. Free Radic. Res. 33: 341-348, 2000.

Blumenstein, J., S-C. Tam, J. E. Chang and J. T. Wong. Experimental transfusion of dextran-hemoglobin. Prog. Clin. Biol. Res. 19:205-212, 1978.

Kabat, E. A. and A. E. Bezer. Effect of variation in molecular weight on the antigenicity of dextran in man. Arch. Biochem. Biophys. 78:306-318, 1958.

Melton, R. G., C. N. Wiblin, R. L. Foster and R. F. Sherwood. Covalent linkage of carboxypeptidase G 2 to solub1e dextrans – I. Properties of conjugates and effects on plasma persistence in mice. Biochem. Pharmacol. 36:105-112, 1987.

Muranishi, S. Drug targeting towards the lymphatics. Adv. Drug Res. 21:1-38, 1991.

Odling-Smee, G. W. and B. G. Wilson. Haemoglobin as a blood substitute. In Blood Substitutes (K.C.Lowe,ed.) New York: VCH, 1988, pp.71-86.

Rosemeyer, H., E. Kornig and F. Seela. Adenosine deaminase covalently linked to soluble dextran. The effect of immobilization on thermodynamic and kinetic parameters. Eur. J. Biochem., 122: 375-380, 1982.

Sherwood, R. F., J. K. Baird, T.Atkinson, C. N. Wiblin, D. A. Rutter and D. C. Ellwood. Enhanced plasma persistence of therapeutic enzymes by coupling to soluble dextran. Biochem. J. 164:461-464, 1977.

Tam, S-C., J. Blumenstein and J. T. Wong.Soluble dextran-hemoglobin complex as a potential blood substitute. Proc.Nat1. Acad. Sci. USA.73: 2128-2131, 1976.

Tam,S-C., J. Blumenstein and J.T. Wong. Blood replacement in dogs by dextran-hemoglobin. Can. J. Biochem. 56: 981-984,1978.

Tam, S-C. and J. T. Wong. Modification of hemoglobin upon covalent coupling to dextran: enhanced stability against acid denaturation and reduced affinity for haptoglobin. Can. J. Biochem. 58: 732-736, 1980.

Tam,S-C., and J.T. Wong. Impairment of renal function by stroma-free hemoglobin in rats. J. Lab. Clin. Med. 111: 189-193, 1988.

Tsai, S.P., and. J. T. Wong. Dextran-Hemoglobin. In Advances in Blood Substitutes. (R.M. Winslow, K.D. Vandegriff and M. Intaglietta, eds) Boston: Birkhauser, 1997, pp. 233-250.

Wileman, T. E., R. L. Foster and P. N. C. Elliott. Soluble asparaginase-dextran conjugates show increased circulatory persistence and lowered antigen reactivity. J. Pharm. Pharmacol. 38: 264-271, 1986.

Wong, J. T. Right-shifted dextran-hemoglobin as blood substitute. Biomat. Art. Cells Art. Organs. 16: 237-245, 1988.

Xue H. and J. T. Wong. Preparation of conjugated hemoglobins. Methods Enzymol. 231: 308-322, 1994.

Xue, H.,X. F. Wu and J. T. Wong. Properties of hemoglobin and dextran-hemoglobin right-shifted by oxidized inositol tetrakisphosphate. Artif. Organs 16: 427-431, 1992.

Yalpani, M. Polysaccharides. New York: Elsevier Science,1988, pp.8-49.


  


 

Notice: The Company information is updated periodically but may not be current at time of visitation. Such information may also contain forward looking statements that are subject to risks and uncertainties that could cause actual results to differ materially, including uncertainties associated with the conduct of clinical trials. It should be noted that Dextro-Sangs's product are currently under development and that regulatory approval for the sale of its product has not been sought or attained.

DEXTRO-SANG™ hemoglobin raffimer and the Logo design are trademarks of Dextro-Sang